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In the thymus, developing T cells receive signals that determine lineage choice, specificity,
MHC restriction and tolerance to self-antigen. One way in which thymocytes receive
instruction is by secretion of Sonic hedgehog (Shh) from thymic epithelial cells. We have
previously shown that Hedgehog (Hh) signalling in the thymus decreases the CD4:CD8
single-positive (SP) thymocyte ratio. Here, we present data indicating that double-positive
(DP) thymocytes are Hh-responsive and that thymocyte-intrinsic Hh signalling plays a role
in modulating the production of CD41 (SP4), CD81 (SP8) and unconventional T-cell subsets.
Repression of physiological Hh signalling in thymocytes altered the proportions of DP and
SP4 cells. Thymocyte-intrinsic Hh-dependent transcription also attenuated both the
production of mature SP4 and SP8 cells, and the establishment of peripheral T-cell
compartments in TCR-transgenic mice. Additionally, stimulation or withdrawal of Hh
signals in the WT foetal thymus impaired or enhanced upregulation of the CD4 lineage-
specific transcription factor Gata3 respectively. These data together suggest that Hh
signalling may play a role in influencing the later stages of thymocyte development.
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Introduction
During ab T-cell development, thymocytes migrate through
distinct thymic microenvironments, receiving signals that deter-
mine their lineage choice, MHC restriction, antigen specificity
and ability to discriminate between self and non-self. Early
uncommitted progenitors migrate into the thymus and give rise
to double-negative (DN) (CD4CD8) cells, which differentiate
into double-positive (DP) (CD41CD81)cells before terminating
expression of one co-receptor to become mature single-positive
(SP) CD41CD8 (SP4) or CD4CD81 (SP8) T-cells. DP abTCR1
thymocytes undergo selection, which ensures production of a
diverse appropriately reactive T-cell repertoire. Other thymus-
derived T-lineage cells include gamma delta (gd) gdTCR1 DN cells.
gd T cells arise from CD251 DN (DN2-3) thymocytes following
successful rearrangement and signalling through a gdTCR.
Although the ligands for gd T cells are not well characterised, gd
T cells may also be selected on cognate self-peptide [1].
The events controlling T-cell lineage choice and selection in
the thymus are not fully understood. Several models attempt to
explain how different TCR signals influence thresholds for
thymocyte selection and differentiation during development [2].
Recent models hypothesise that TCR signals of differing strength,
duration and kinetics are integrated with local stromal influences
[3], including cytokine signalling [4, 5], morphogen signalling
[6] and Notch signalling [7], to regulate lineage choice and
selection.
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Several lineage-specific transcription factors including Tox,
ThPOK, Runx3 and Gata3 have been identified as important in
CD41 versus CD81 T-cell maturation [8]. Expression of Gata3
increases after positive selection on MHC class II-restricted
ligands, and loss of Gata3 impairs CD41 T-cell differentiation,
whereas overexpression inhibits the production of CD81 T cells
[9]. Gata3 expression has been correlated with TCR signal strength
[9]. This is consistent with the fact that longer, stronger TCR signals
are thought to favour CD41 T-cell lineage commitment [10], and
that CD41 thymocytes express higher levels of Gata3 than SP8 cells.
It has been suggested that Gata3 itself acts to enhance TCR
expression and signalling in developing SP4 cells [11].
Thymic epithelial cells (TECs) direct T-cell development by
signalling to maturing thymocytes. One-way TECs signal to
thymocytes is by the secretion of Sonic hedgehog (Shh), which
activates the Hedgehog (Hh) signalling pathway in thymocytes
[6, 12–17]. Hh proteins are morphogens and are essential for
organogenesis during embryonic development [18]. Morphogens
specify cell fate by establishing a concentration gradient, in which
the target cell’s position relative to the morphogen source
determines morphogen signal strength, regulating differentiation
and patterning in a spatial and temporal manner. This is impor-
tant in an organ such as the thymus, where cells transit through
unique microenvironments during development. The down-
stream mediators of Hh signals are the Gli proteins (Gli1, Gli2,
Gli3), which bind to DNA at consensus Gli-family binding sites
[19] and directly modulate target gene transcription. Gli2 acts
mainly as a transcriptional activator but is processed to activate
or repress transcription by post-translational modification of the
N- or C-terminus, in the presence or absence of Hh, respectively
[20]. Strength and duration of the Hh signal determines the
balance of intracellular Gli Repressor (R) and Gli activator (A)
protein forms, on which transcriptional outcome depends.
Analysis of genetically modified mice has revealed multiple
functions for Hh signalling during thymocyte development [6].
Studies on the selection of class I-restricted transgenic TCR have
indicated that Hh-pathway activation reduces positive and
negative selection to the CD81 T-cell lineage [16, 21], and
influences the CD4:CD8 ratio, decreasing the proportion of CD41
T cells [16]. A direct influence of Hh signalling on the selection of
the CD41 T-cell lineage has not, however, been demonstrated,
and this is of interest given that distinct transcriptional programs
direct CD41 and CD81 T-cell development.
In Shh/ embryonic thymi, Shh signalling is lost from all
cells and therefore the observed effects on thymocyte selection
could be indirect, through Shh signalling to another cell type [22,
23], or due to Shh-deficiency adversely affecting thymus orga-
nogenesis or architecture. In order to test whether Shh is
signalling directly to thymocytes, we use a transgenic Lck-driven
Gli2DC2 transcriptional repressor to inhibit the ability of a
thymocyte to receive a physiological Hh signal. Lck-Gli2DC2
(C2, Gli2R) transgenic mice [24] express a truncated form of
Gli2, which acts as a repressor of Hh-dependent transcription.
The reciprocal Lck-Gli2DN2 (non-TCR-transgenic-Gli2DN2 (N2),
Gli2A) transgene also encodes a truncated form of Gli2 that leads
to constitutive activation of Gli2-dependent transcription in T-
lineage cells [16]. Both transgenic constructs are otherwise
identical in sequence, sharing DNA-binding domains.
Here, we investigate the consequences of repressing or acti-
vating Hh signalling in thymocytes on the production of mature
SP T cells.
Results
Repression of Hh signalling in thymocytes moderately
increases the proportion of SP4 cells
We have previously shown that activation of Hh signalling in
thymocytes causes a decrease in the production of SP4 cells [16].
Conversely, the absence of Shh in knockout embryos resulted in
an increase in the proportion of SP4 cells and a higher SP4:SP8
ratio [16]. Repression of endogenous Hh signalling also caused a
relative increase in the proportion of SP cells [24], indicating a
physiological role for Hh in the development of SP thymocytes. In
order to confirm this, we analysed Gli2R (C2) transgenic and WT
littermate thymi, and found a reduction in the percentage of DP
cells, and a selective increase in the percentage of SP4 cells in C2
transgenics (Fig. 1A and B). The absolute number of DP cells was
also decreased and there was a trend towards decreased total
cellularity in the C2 thymus (Fig. 1A). In terms of absolute cell
number, we noted an increase in the number of SP4 cells relative
to the number of DP cells, which decreased, in the C2 thymi (Fig.
1C). We were therefore interested to further examine the role of
Hh signalling in the DP to SP transition.
DP thymocytes express Smo and are Hh-responsive
during selection events
Components of the Hh signalling pathway are expressed in mouse
[12] and human [25] thymus. In order to confirm that thymocytes
express the machinery required for transduction of Hh signals, we
sorted DN, DP and SP4 thymocytes from WT mice and performed
qPCR to measure relative expression of Smo, the Hh signal
transduction molecule. Smo was expressed in all subsets, with a
graded decrease in the expression level as cells increase in maturity
(Fig. 1D). We also detected Smo transcript in TCRaKO DP
thymocytes, indicating that DP cells have the capacity to respond
to Hh signals in the absence of TCR expression, although expression
was lower than in TCR-competent WT DP cells. We then sorted pre-
(CD3CD69) and post-selection (CD31CD691) DP cells from
WT mice to confirm that cells undergoing positive selection are
able to receive Hh signals (Fig. 1E). To confirm that pre-
selection DP thymocytes are Hh-responsive, we treated TCRaKO
DP thymocytes with recombinant (r) Shh and measured
expression of the Hh target gene Ptch1. Ptch1 was upregulated
in response to Shh treatment (Fig. 1F), demonstrating that DP
thymocytes can transduce Hh signals, independent of TCR
expression.
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Transgenic repression of Hh signalling in thymocytes
increases the SP4:SP8 ratio
To test the effect of inhibition of physiological Hh signalling on
the differentiation of DP thymocytes, we followed the DP to SP
transition in transgenic Gli2R (C2) foetal thymic organ culture
(FTOC). The use of FTOC allowed us to follow the differentiation
from DP to SP in a situation where development is synchro-
nised before establishment of the mature steady-state SP
populations, which may include recirculating cells. After 7
days in culture, the SP4:SP8 ratio was raised in the C2 thymi
compared with WT (Fig. 1G, p5 0.0003). Within the whole
SP4 subset there was an increased percentage of CD31 cells in
C2 (Fig. 1H). Additionally, a greater proportion of SP4 cells
expressed CD5 with a higher mean fluorescent intensity (MFI)
in C2 compared with WT (Fig. 1I), suggesting that TCR
signalling was stronger in SP4 CD51 cells when Hh signalling
was repressed.
These experiments suggest that inhibition of physiological
Hh-dependent transcription in thymocytes increased differ-
entiation to SP4, as in the Shh/ embryo [16]. The C2
transgene encodes Gli2R protein, which competes with endo-
genous GliA protein (Gli1, Gli2A and Gli3A) present in the cell.
Therefore, if the Hh pathway were not active in the cell, the C2
transgene would have no functional effect as there would be no
GliA with which it could compete for Gli-binding sites, and all
endogenous Gli protein would also be in repressor form. To
test whether the effect of the transgenic Gli2R was saturating
in its competition with endogenous GliA, we compared
differentiation in FTOC in which copy number of the C2
transgene (threefold that of Gli2 in WT mice [24]) was
doubled by mating transgenics (C2C2). C2C2 embryos
showed a slight enhancement in SP4:SP8 ratio, %CD31SP4
and % and MFI CD5 on SP4 cells (Fig. 1G-I), suggesting that C2
transgene inhibits but does probably not completely abrogate
Gli2A function.
Inhibition of Hh signalling increases positive selection
of CD81 T cells in the HY-TCR Tg thymus
The HY-TCR recognises the Y-chromosome-derived peptide Smcy,
in the context of Db. In females, developing thymocytes are
positively selected and preferentially directed to the CD81 T-cell
lineage [26]. To investigate the impact of repression of
physiological Hh signalling in thymocytes on the selection of
CD81 T cells, we crossed HY TCR transgenic mice to Lck-Gli2DC2
animals to generate the C2HY strain.
To assess positive selection of the transgenic TCR, we exam-
ined thymi from female C2HY mice. We found a modestly
increased proportion of antigen-specific DbSmcy tetramer1 cells
(Tet1) SP8 cells in HY compared with C2HY thymi and a
concurrent decrease in the proportion of DP cells in the Tet1 gate
in C2HY (Fig. 2A and B, p5 0.01). In terms of absolute cell
number we noted that there was a greater number of Tet1SP8
cells (HY: 20.673.9 106; C2HY: 24.076.6 106) relative to
the number of Tet1DP cells (HY: 13.872 106; C2HY:
9.972.5 106) in C2HY (Fig. 2C). This is consistent with
moderately enhanced positive selection of HY cells to the CD81
T-cell lineage in female C2HY mice, as more of the Tet1 cells have
differentiated to SP8. We did not observe any overall change in
thymocyte number in C2HY females (Fig. 2D).
Figure 1. DP cells are responsive to Hh signalling, and repression of Hh
signalling in thymocytes enhances SP4 differentiation in FTOC. (A) WT
and C2 thymi were analysed by flow cytometry for CD4 and CD8
expression. The number underneath each representative flow cyto-
metry plot indicates the mean total thymic cell count7SEM for WT
(n5 6) and C2 (n5 9) mice. (B) The proportions of cells in the thymocyte
subsets shown in (A) were quantified in WT (white bars, n5 6) and C2
littermates (shaded bars, n5 9, p5 0.01, WT is compared with C2 for
each subset using Student’s t-test). (C) Mean absolute numbers of
cells7SEM in DP (WT 142.6734.7 106; C2 106.8720.2 106) and SP4
(WT 15.374.9 106; C2 15.673.7 106) was determined for WT (n5 6)
and C2 (n5 9) mice and the ratio of the number of DP cells to SP4
calculated. (D, E) Smo expression (AU, arbitrary units) relative to Hprt
expression measured by qPCR in (D) WT DN, DP and SP4 sorted cells,
and in TCRaKO DP cells and (E) in sorted pre-selection (CD3-CD69)
and post-selection (CD31CD691) WT DP cells. (F) Ptch expression
relative to Hprt expression was measured by qPCR in TCRaKO DP cells
cultured for 24 h in the presence/absence of 500 ng/mL rShh. All qPCR
experiments show mean7SD of triplicates and are representative of at
least two independent experiments. (G) WT, C2 and C2C2 E15.5
FTOCs were cultured for 7 days and the proportion of DP and SP
thymocytes in WT (n5 7), C2 (n5 5) and C2C2 (n5 9) FTOCs analysed.
Representative flow cytometry plots are shown and the SP4:SP8 cell
ratio was calculated for all FTOC and presented as mean7SEM (t-test
WTvC2 po0.02, WTvC2xC2 po0.0001; one-way ANOVA, p5 0.0003).
Relative expression of (H) TCR CD3 and (I) CD5 on SP4 cells. MFI of cells
in the CD51 peak is indicated in large type. For (H) and (I) data were
obtained for WT (n5 7), C2 (n5 5) and C2C2 (n5 9) thymus lobes, the
plots are representative.
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Inhibition of Hh signalling in thymocytes enhances
deletion from the CD81 T-cell lineage
In the male HY thymus, there was extensive deletion, although
we observed further decreases in the proportion of DP and SP8
cells and HY-TCR1 (T3.701) cells in C2HY thymi (Fig. 2E) and a
reduction in thymus cellularity (Fig. 2D, po0.05). We found a
modest decrease in the proportion of SP8 cells expressing the
HY-TCR, with T3.70hi CD81 thymocytes being virtually absent in
the C2HY group (Fig. 2F, po0.01), and consistent decreases in
cell numbers in these subsets (Fig. 2G).
Given that repression of Hh signalling enhanced both
positive and negative selection (i.e. enhanced both survival
and clonal deletion of thymocytes dependent on gender in the
HY thymus) it seems unlikely that its effect is by the modula-
tion of cell death or proliferation. These observations, together
with our previous data [16, 17, 21], are consistent with Hh
subtly modulating TCR signal strength or thresholds for TCR
signalling.
Hh-dependent transcription attenuates development
of unconventional T-cell subsets
Development of ‘unconventional’ CD4CD8 DN TCR1 cells is
associated with strong TCR signalling and these cells are most
prevalent in TCR transgenic models where cognate antigen is
expressed [27]. HY-TCR transgenic male mice contain a large
population of these cells, which are thought to have received
strong TCR signals as DN thymocytes as a result of premature
expression of transgenic abTCR [28–30]. As active Hh signalling
attenuates selection of conventional T cells, we hypothesised that
development of other TCR-dependent lineages would be altered.
To test this, we examined lymph node DN cells for the
expression of CD3 in our HY crosses (Fig. 3A). Overall, there
was a statistically significant decrease (approx. 40%) in the
relative proportion of these cells in the N2HY males versus
HY males (Fig. 3B, p5 0.0004), and a modest increase in
C2HY males compared with the HY littermates (Fig. 3B, % of
HY, po0.04).
These cells display characteristics similar to gdT-cells and
may share a developmental origin [31]. We therefore investi-
gated the peripheral gdTCR1 pool in N2 mice, where Hh-
dependent transcription is constitutively active in DN cells
[16, 17]. Although selection of gd-lineage cells is incom-
pletely understood, differentiation to this lineage has been
proposed to require relatively strong TCR signals [32] and
to occur in the DN2-3 population. The percentage of
CD4CD8CD31gdTCR1 T-cells in the N2 lymph nodes was
reduced, typically 0.9% compared with 1.9% in WT (Fig. 3C and
D, p50.002). We found no difference in gdT-cells in C2 mice
(data not shown).
Deletion by endogenous superantigen is impaired
when Hh signalling is constitutively active in T cells
To assess the impact of active Hh signalling on a very strong
physiological TCR signal, we investigated thymocyte deletion by
endogenous superantigens. In certain mouse strains, endogenous
superantigens encoded by incorporated Mtv genomes mediate
deletion of cells expressing particular Vb segments. We crossed
Gli2DN2 and BALB/c mice. T cells expressing the Vb11 gene
segment are efficiently deleted from the repertoire of I-E1 BALB/c
or F1 offspring by endogenous Mtv8 and Mtv9 [33]. We
examined frequency of Vb111 lymphocytes escaping deletion in
Figure 2. Positive selection and clonal deletion of CD81 T cells is
enhanced by repression of Hh-dependent transcription in thymocytes.
(A) Representative staining of thymocytes from HY and C2HY female
mice with anti-CD8, -CD4 and DbSmcy tetramer. (B) %DPTet1 and
%SP8Tet1 cells were analysed in groups of female HY (white bars, n5 4)
and C2HY (shaded bars, n5 6, p5 0.01) mice as defined in (A), and
absolute cell numbers were then calculated as mean7SEM: Tet1DP
cells (HY: 13.872106; C2HY: 9.972.5106) and Tet1SP8 cells (HY:
20.673.9106; C2HY: 24.076.6 106). (C) For all mice in (B), the ratio of
the number of Tet1SP8 cells to Tet1DP cells was calculated and is
displayed as mean7SEM (p5 0.0006). (D) Mean7SEM thymus cellu-
larity in female HY (white bar, n5 5) and C2HY (grey bar, n5 7) groups,
and male HY (white bar, n5 5) and C2HY (grey bar, n5 4, po0.05)
groups. (E) CD4, CD8 and HY-TCR a-chain1 (T3.701) expression on
thymocytes representative of male HY (n5 5) and C2HY (n5 4) mice. (F,
G) Mean7SEM of percentages (F) and absolute numbers (G) of CD81
T3.701 or T3.70hi (HY group compared with C2HY group: po0.01)
thymocytes compared between HY (white bars, n5 5) and C2HY
(shaded bars, n5 4) groups.
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F1 mice. In both CD41 and CD81 populations, the presence of the
N2 transgene moderately increased the percentage of Vb111 cells
(Fig. 3E), and this was most evident in the CD81 subset. On
average there was a consistent increase of20% in N2 than WT
populations (Fig. 3F, po0.05). Selection of cells expressing
another non-deleted gene segment (Vb8.2) was comparable in all
mice (Fig. 3G).
Thymocyte-intrinsic Hh signalling attenuates selection
of CD41 T cells in the ABM-TCR transgenic thymus
As the role of Hh signalling has not been explored in positive
selection of cells to the CD41 lineage, we crossed N2 and C2 mice
to the ABM-TCR transgenic [34]. The ABM-TCR is positively selected
on I-Ab and skews selection to the CD41 T-cell compartment.
To investigate the effect of constitutive Hh-dependent tran-
scription on CD41 T-cell development, we examined the thymi of
N2ABM mice and ABM littermates. The percentage of cells in
thymocyte subsets were similar between groups (Fig. 4A)
although there was a relative increase in the proportion of DN
cells in the N2ABM group of approximately 20% (Table 1,
p50.03), consistent with the known effects of Hh signalling on
DN cell differentiation [12, 17, 35]. There were fewer cells in
N2ABM thymi, with decreased numbers of DP, SP4 and SP8 cells
(Fig. 4B, po0.03). The proportion of Va21 SP4 cells was lower in
N2ABM thymi compared with ABM (Fig. 4C and Table 1,
po0.03), indicating reduced differentiation from DP to SP4. The
number of Va21 thymocytes was also decreased in N2ABM thymi,
with statistically significant reductions in cell number in the Va21
SP compartments (Fig. 4D, p50.02). CD69 expression was
increased on SP4 cells from N2ABM compared with ABM litter-
mates (Fig. 4E), and there was a slight shift in human serum
albumin (HSA) staining, where more cells expressed this imma-
turity marker with higher MFI in N2ABM (Fig. 4E). CD69 is
Figure 3. Development of unconventional T-cell subsets is attenuated
by Hh signalling in T-lineage cells. (A) Expression of CD3 on DN
(CD4CD8) LN lymphocytes in male HY and N2HY mice. Results are
representative of HY (n5 8) and N2HY (n5 6) mice. (B) Proportion
(mean7SEM) CD31DN LN T-cells in male N2HY (n5 6) and C2HY (n5 5)
mice calculated as a percentage of that in the relevant HY littermate
groups (po0.04, po0.0004 in comparison with the relevant HY
littermate groups). (C) Representative flow cytometry plots and (D)
quantified percentages (mean7SEM for WT n5 4, N2 n56, po0.0001) of
CD31gdTCR1 cells in the CD4CD8 gate of LN T cells. (E) Representa-
tive flow cytometry plots of Vb11 expression on LN CD41 and CD81
T cells of WT and F1 mice from N21C57BL/6 by BALB/c crosses. (F)
Proportion (mean1SEM) of CD41 or CD81 Vb111 T cells in the N21 F1
group (n5 6) calculated as a percentage of that in WT F1 littermates
(n5 6) (set to 100%) (po0.05 compared with the WT F1 littermates). (G)
Representative flow cytometry showing Vb8 expression in LN CD41 and
CD81 T cells of F1 mice from N2 C57BL/6 by BALB/c crosses.
Figure 4. Influence of Hh-dependent transcription on the selection of
CD41 T cells. (A) Representative ABM and N2ABM CD4/CD8 thymus
profiles and (B) quantified (mean1SEM) thymocyte cell subset numbers
in ABM (n5 4) and N2ABM (n5 5, po0.03) groups. (C) Representative
CD4/CD8 profiles within the Va21 gate and (D) quantified (mean7SEM)
cell numbers in the indicated thymocyte subsets of all ABM (n5 4) and
N2 ABM (n5 5, po0.05) mice within the Va21 gate. For B and D, means
were compared between ABM (white) and N2ABM (shaded) groups for
each subset. (E) Plots of the expression of CD69 and HSA on SP4
thymocytes, representative of ABM (n5 5) and N2ABM (n5 8, %CD69
p5 0.008; %HSA p5 0.01) groups, MFI is in italics. (F) CD4/CD8 thymus
profiles representative of ABM (n5 6) and C2ABM (n5 7) mice. (G) CD4/
CD8 profiles within the Va21 gate (ABM TCR1) representative of ABM
(n5 5) and C2ABM (n5 6) mice.
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upregulated upon lymphocyte activation, but during thymocyte
maturation SP cells must downregulate this molecule in order to
exit the thymus [36]. Fully mature SP cells, recent thymic
emigrants and naive T cells express low levels of CD69 and HSA
[37]. Our data therefore suggest that production of SP4 cells is
impaired when Hh signalling is active, and that a larger propor-
tion of the SP4 population is immature in N2ABM compared with
ABM thymus.
The thymi of C2ABM mice appeared comparable to ABM
littermates (Fig. 4F) and we found no differences in the
proportions of TCRhi Va21ABM populations in C2ABM mice (Fig.
4G, Supporting Information Table 1). The fact that the C2
transgene did not increase positive selection of the ABM TCR
could be because positive selection of the relatively low percen-
tage of cells expressing the ABM transgene was already efficient
or optimal. Alternatively, it is possible the single copy number of
the C2 transgene in C2ABM mice is not sufficient to fully repress
all effects of physiological Hh-dependent transcription (Fig. 1) on
the selection of ABM1 CD4 cells.
Hh signalling influences establishment of the periph-
eral T-cell compartment in the ABM-TCR transgenic
When we examined spleen, we found no differences in the
proportions of T cells or Va21 cells in the C2ABM compared with
ABM littermates (Fig. 5A and B and Supporting Information
Table 2). However, there were on average 30% more splenocytes
in C2ABM compared with ABM mice (Fig. 5C, po0.0005). We did
not detect an increase in blasting cells or in the expression of
activation markers between ABM and C2ABM CD41 T cells,
ruling out a lymphoproliferative disorder (data not shown). The
only cell population that contained statistically significantly more
cells in the C2ABM spleen was the CD41 T-cell subset
(Supporting Information Table 3, po0.05), but when we gated
on Va21 cells, the number of cells in each population was
equivalent between the two genotypes.
Non-TCR-transgenic C2 mice display comparable spleen cell
numbers to WT littermates [24], indicating that the increase in
spleen cell number seen in C2ABM mice requires the presence of
both the transgenic TCR and Gli2R. However, the fact that there
was no significant increase in Va21 CD41 T cells, but only in the
overall CD41 population, suggests that the increase in spleen size
is the result of a bystander effect, most likely via TCR transgene-
dependent cytokine signalling. We thus propose that the ABM
TCR1 C2 cells produce factors favourable for survival or prolif-
eration, influencing homeostasis/survival of other T- and non-T
cells.
Conversely, we found decreases in splenocyte number (Fig.
5C, po0.002) and percentage of CD41 T-cells (Fig. 5D and
Table 2) in N2ABM spleen compared with ABM littermates. CD41
cell number was decreased (Fig. 5E, p50.004), as was the
number of DN cells (Fig. 5E, p50.03). The percentage of CD41
CD5hi cells was reduced in splenocytes from N2ABM (Fig. 5F),
suggesting that a proportion of CD41 T cells signal with lower
TCR strength in the N2ABM. When gating on Va21 cells, we
Table 1. Thymocyte subset percentages in N2ABM crossesa)
% Live thymocytes % Va21 thymocytes
ABM n5 5 N2ABM n58 ABM n54 N2ABM n5 6
DN 8.970.8 11.272.1 38.676.8 45.674.4
DP 79.173.1 77.673.7 17.374.2 18.775.9
SP4 9.772.2 8.871.9 36.275.4 30.171.6
SP8 2.470.5 2.470.5 8.073.1 5.670.8
a)Thymus was analysed by flow cytometry. Percentages of DN, DP, SP4
and SP8 thymocytes falling in the live lymphocyte and Va21 gates
were defined by CD4 and CD8 expression. p5 0.02, p5 0.03.
Figure 5. TCR-dependent peripheral establishment of the CD41 T-cell
compartment is attenuated by Hh signalling in T cells. (A, B) CD4/CD8
spleen profiles representative of ABM (n5 6) and C2ABM (n5 6) (A)
within live gates and (B) representative of ABM (n5 4) and C2ABM
(n5 5) within Va21 gates. (C) Spleen cell number (mean1SEM) of ABM
(n5 7) and C2ABM (n5 7) littermate groups, and ABM (n5 4) and
N2ABM (n5 8) littermate groups (po0.02). (D) CD4/CD8 spleen profiles
representative of ABM (n5 5) and N2ABM (n5 8) mice. (E) Cell numbers
(mean7SEM) within spleen cell subsets of ABM (n5 5) and N2ABM
(n5 8, po0.03) mice. (F) Expression of CD5 (% positive) on CD41
splenocytes representative of ABM (n5 4) and N2ABM (n5 8) mice
(p5 0.04). (G) Spleen CD4/CD8 profiles within the Va21 gate represen-
tative of ABM (n5 5) and N2ABM (n5 8). (H) Cell numbers (mean1SEM)
in Va21 splenocyte subsets of ABM (n5 5) and N2ABM (n5 8, po0.0007)
groups. Within splenocyte subsets in E and H, cell number is compared
between ABM (white bars) and N2ABM (shaded bars).
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noted a decrease in the percentage and number of N2ABM Va21
CD41 T cells, and a concurrent increase in the percentage of
Va21 CD81 T cells (Fig. 5G and H, Table 2, po0.007). In non-
TCR transgenic N2 mice, splenocyte number is equivalent to WT
[16], indicating that the decrease in splenocyte number in the
N2ABM mice is also transgenic TCR-dependent.
Gli2 modulates expression of Gata3 in developing
thymocytes
Differentiation of CD41 T cells was impaired by Gli2A expression
in the N2ABM cross (Fig. 4). This supports our previous
observation that WT FTOC treated with Shh display decreased
proportions of SP4 cells [16] and demonstrates that this effect is
T-cell-intrinsic. Conversely, SP4:SP8 ratios were raised in Gli2R
FTOC (Fig. 1), as in Shh/-foetal thymus [16]. Gata3 is
upregulated in SP4 cells following selection on MHC class II
ligands, and is thought to be required to reinforce CD41 lineage
commitment and promote maturation of these cells [9]. To test
whether Gata3 expression was modulated by the presence of
Gli2A, we performed intranuclear staining on thymocytes from
non-TCR transgenic N2 mice, which display a reduced SP4:SP8
ratio [16]. There were fewer Gata31 cells in the SP4 subsets in
N2 compared with WT thymi (Fig. 6A–C, p50.03), indicating a
decreased proportion of cells fully committed to the SP4 lineage.
There was also a trend towards decreased expression in N2 DP
cells, suggesting that these cells upregulated Gata3 less efficiently
than WT cells during positive selection.
It has been suggested that Gata3 expression in thymocytes is
influenced by TCR signal strength [9], which may be attenuated
by Hh signals. To assess the relationship between TCR signal
strength, Gata3 expression and SP4:SP8 development, we
examined expression of Gata3 in HY-TCR transgenic thymocytes.
As expected, we found low levels of Gata3 in DP and SP8 cells,
particularly in HY TCRhi (T3.701) SP8 cells, of female mice (Fig.
6D). However, a significantly higher proportion of male HY cells,
particularly SP8 cells, express Gata3 (Fig. 6D and E). This indi-
cates that thymocytes undergoing strong TCR signals via contact
with cognate antigen can upregulate Gata3 even in the inap-
propriate SP lineage subset, and confirms that strong TCR signals
are linked to enhanced expression of Gata3.
Gata3 expression in SP4 thymocytes is controlled by
physiological Hh signalling
In order to test the hypothesis that Gata3 induction at the DP to
SP4 transition is impaired by Hh signalling in non-transgenic
systems, we cultured E17.5 WT FTOC in the presence or absence
of rShh for 48 h and measured levels of Gata3 expression over DP
to SP transition. Treatment of WT FTOC with rShh for this short
period did not alter the proportions of DP or SP4 cells (Fig. 7A),
but caused a decrease in the proportion of DP and SP4 cells
expressing Gata3 (Fig. 7B and C, po0.02), and in the MFI of
Gata3 staining (Fig. 7D, po0.01). Conversely, withdrawal of
endogenous Hh signals in WT FTOC by culture with neutralising
anti-Shh mAb (5E1) increased the proportion of DP and SP4
Gata31 cells (Fig. 7E and F, po0.0001), and enhanced Gata3 MFI
(Fig. 7G, po0.001).
These data illustrate that physiological Hh signalling can
negatively regulate Gata3 expression in developing thymocytes.
Table 2. Splenocyte subset percentages in N2ABM crossesa)
% Live splenocytes % Va21 splenocytes
ABM n55 N2ABM n58 ABM n55 N2ABM n5 8
DN 85.874.6 90.272.3 13.878.1 24.679.7
CD4 11.173.0 5.971.1 79.378.0 58.777.6
CD8 2.471.6 3.171.8 6.071.4 12.172.3
a)Spleen was analysed by flow cytometry. Percentages of DN, CD41 and
CD81 splenocytes falling in the live splenocyte and Va21 gates were
defined by CD4 and CD8 expression. p5 0.01, po0.0007.
Figure 6. Gata3 expression is regulated by Hh-dependent transcrip-
tion. (A) Representative and (B, C) quantified (total mean7SEM)
intracellular Gata3 expression in DP and SP4 thymocytes from WT
(n5 7) and N2 (n5 9, p5 0.03) thymi. (D) Representative and (E)
quantified (total mean1SEM) Gata3 expression in HY TCR transgenic
male (n5 5) and female (n5 4, male vs. female p5 0.007; p5 0.0008)
DP, SP4 and SP8 thymocytes, and (D) in T3.70hi (HY TCRahi) DP and SP8
cells. Shaded histograms show isotype control staining.
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Discussion
Here we present data indicating that physiological Hh pathway
activation in immature thymocytes contributes to the complex
regulation of differentiation from DP to SP cell. However, it is
important to note that some of the differences observed in our
models were small, although reproducible and statistically
significant. The statistical significance of the data is tight (low
p-values) and the data broadly support one another, reinforcing
the conclusion that it is highly unlikely that the results are due to
chance. TCR transgenics in particular tend to be sensitive
systems; therefore, the true biological significance to endogenous
TCR repertoire selection remains to be determined. However, in
this manuscript we show data consistent with previously
published data [16, 21, 24, 38] and with our hypothesis that
Hh can attenuate the DP to SP transition, by using many different
experimental systems. It should also be noted that the biology of
the HY and ABM TCRs may not be reflective of all class I- and
class II-restricted TCR respectively. This work, therefore, requires
further experiments to clearly define Hh’s role in the negative
regulation of the later stages of thymocyte development.
Nevertheless, we here demonstrate that DP cells express Smo
and are able to transduce Hh signals. In addition, we show that
Hh signalling can influence differentiation of T-cell populations,
including CD41, CD81, DN abTCR1 T cells and gdT-cells, and
that there is a role for Hh signalling in regulating the peripheral
T-cell compartment.
We have previously shown that transgenic Gli2A (N2)
expression reduced positive and negative selection of HY-TCR1
cells to the CD81-lineage [16]. Here we demonstrate a reciprocal,
if milder, effect of C2 on the development of HY thymo-
cytes. Additionally, use of the ABM-TCR allowed us to test
whether Hh signalling also specifically influences development
of the CD41 T-cell lineage. Gli2A expression constrained thymus
size by attenuating production of mature ABM CD41 T cells
and limited the establishment of selected cells in the periphery.
We noted no lineage redirection to CD81 T cells in the thymus,
only observing significant decreases in the proportion and
number of CD41 T cells. Gli2R did not notably affect thymic
development of the ABM-TCR1 CD41 T cells. This may be due to
the affinity of the ABM-TCR used for selecting ligand, where
the partial repression of Hh signalling is not sufficient to
‘enhance’ selection of this particular TCR because positive
selection is already maximal. However, C2ABM mice displayed
an increased population of CD41 splenocytes, suggesting a
potential role for Hh signalling in the homeostasis/survival of
peripheral T-cells, and that this may be dependent on Class II
restricted TCR.
As seen in the Shh/ thymus [16], Gli2R expression
moderately increased differentiation from DP to SP4 in a non-
TCR Tg background. This demonstrates that physiological Hh
pathway activation in thymocytes plays a role in attenuating
development at this transition, and that the effect of Shh on
differentiation is at least in part by signalling direct to thymo-
cytes, and not only via an intermediate cell type.
The use of transgenes is always open to the criticism that
unexpected effects (for example, due to integration site) may be
introduced. However, it is important to note that in our study,
transgenic expression of Gli2A and Gli2R consistently gave reci-
procal (and opposing) phenotypes. This suggests that the effects
are a direct result of Gli2 activity and not due to an artefact of
transgenesis, particularly as the constructs used are identical
except for the respective mutations in the Gli2 gene. In addition,
the data presented are consistent with previously published
experiments in which WT FTOCs were treated with rShh [16].
We found in general that the phenotype of the C2 crosses was
less pronounced than those expressing Gli2A (N2). This may be
due to difference in transgene copy number between the strains
[16, 24], although it is possible that overexpression of the tran-
scriptional activator would have a more profound effect than the
repressor because the Gli2R protein is more rapidly targeted for
degradation [39]. Doubling C2 copy number resulted in a small
increase in maturation to SP4 with raised expression of CD5,
suggesting stronger/longer TCR signalling [40]. This also
suggests that not all Hh signalling is suppressed in C2 cells. The
use of the Gli2R transgene as an alternative to a knockout
provides information regarding the physiological Hh signalling
potential of the cell as differences in transcription will only be
evident when a Hh signal is present. Therefore, we demonstrate
that physiological Hh signals may contribute to limiting DP to
SP4 differentiation.
The kinetic signalling model of T-cell differentiation proposes
that DP cells become committed to the CD4 lineage following
sustained TCR/co-receptor signalling [2], and expression of the
appropriate lineage-specific transcription factors (reviewed in
[41]). Our data support a potential role for Hh signalling in
reducing the impact of TCR signals as we show that Hh signals
can limit the production of SP cells in TCR transgenic models,
attenuate the development of high affinity DN T-cells and rescue
a proportion of T-cells from Mtv-mediated deletion. Early, strong
TCR-signals in the thymus favour gdT-cell development, and
these cells express high levels of Smo, indicating potential to
transduce Hh signals [42]. Our data also indicate that Hh
signalling can restrict gdT-cell production. This is in contrast to a
report in which excision of Smo depleted the gdT-cell pool [15],
although this may have been due to the profound effect of
early Smo deletion resulting in the loss of T-cell precursors, which
require Hh for further development [13, 15]. DN T cells
have been proposed to share transcriptional features with gd
T cells, suggesting that they may also have received a strong
TCR-signal early in development. Shh signalling negatively regu-
lates pre-TCR-induced differentiation at the DN3 stage [12, 17];
therefore, it seems likely that as in Gli2A thymus, Hh could
negatively regulate the development of both gd and DN T-cell
precursors.
During differentiation to the CD41 lineage, TCR signal strength
is believed to influence Gata3 expression in SP4 thymocytes [9,
11]. Our data support this, particularly as HY male thymocytes
express high levels of lineage-inappropriate Gata3. Withdrawal of
Hh signals from WT thymi resulted in an increase in Gata3
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expression, and reducing Hh signalling resulted in an increased
yield of mature SP4 cells and higher SP4:SP8 ratio [16] (Fig. 1).
We therefore propose a potential model where physiological Hh
signals can partially suppress Gata3 induction in developing
thymocytes, which combined with, or as a result of, attenuated
TCR signal strength limits the terminal differentiation of SP4 cells.
Shh is expressed and secreted by sub-populations of TECs in
the thymic cortico-medullary junction and medulla [12, 15, 25].
Therefore, the Shh signal that a thymocyte receives depends on
its position in the thymus, and will vary as cells transit through
the thymus during development. Variations in TCR strength at
different stages of differentiation as cells migrate through the Hh
microenvironment could have important consequences on the
outcome of repertoire development. In addition, subsets of
dendritic cells in the spleen also express Shh [22]. It will there-
fore be of interest to investigate the role of Hh-signalling in
peripheral lymphocyte homeostasis, effector differentiation,
tissue inflammation and tumour surveillance in addition to
further dissecting its role during thymocyte development.
Materials and methods
Mice
Lck-Gli2DN2 (N2, Gli2A) [16] and Lck-Gli2DC2 (C2, Gli2R) [24]
transgenic mice and HY-TCR transgenic mice were as described
[26, 43]. ABM-TCR transgenic mice were a gift from Ed Palmer
(Basel, Switzerland) [34]. C2HY, C2ABM and N2ABM mice were
generated from appropriate strains. TCRaKO mice were as
described [44]. All experiments were performed with littermate
controls. Mice were bred at UCL facilities, under UK Home Office
regulations.
FTOC
E15.5 C2C2 thymi were cultured for 7 days on 0.8 mm filters
(Millipore) in AIMV medium (Invitrogen). For Gata3 expression
Figure 7. Physiological Hh signalling attenuates Gata3 expression in DP and SP4 cells. (A) Example of the CD4/CD8 gating strategy used for FTOC
cultures. (B) Representative; bars show % Gata 31 Italic numbers show MFI, and (C) quantified (mean of litters1SEM) intracellular Gata3 expression
in WT (C57BL/6) DP and SP4 cells from E17.5 paired embryonic thymus lobes (n5 11 embryos, one lobe per treatment, po0.02) following 48 h
culture in the presence or absence of rShh (500ng/mL). (D) Change in MFI of Gata3 staining after treatment of these lobes from a representative
experiment (one litter of six embryos). (E-G) WT E17.5 paired embryonic thymus lobes (n5 12 embryos, one lobe per treatment, po0.001) were
cultured for 48 h with or without anti-Shh neutralising mAb 5E1 (5 mg/mL). (E) Representative flow cytometry plots; bars show %Gata31, italic
numerals show MFI. (F) Quantified (mean of litters7SEM) intracellular Gata3 expression and (G) MFI of Gata3 staining after 5E1 treatment shown
for a representative experiment (one litter of six embryos). Representative MFI of Gata3 staining in (D) and (G) compares untreated and treated
lobes from the same embryo respectively. Paired t-tests assessed significance in (C, D, F and G) with and without treatment (po0.01, po0.001).
Shaded histograms show isotype control staining.
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experiments, paired E17.5 C57BL/6 thymi were cultured for 48 h
in the absence or presence of 500ng rShh (R&D Systems) or
5mg/mL 5E1 (anti-Shh mAb, DHSB, University of Iowa, USA).
Flow cytometry and antibodies
Cells were stained as described [45] using antibodies from BD
Pharmingen or eBiosciences. Intranuclear staining was
performed using the eBiosciences Foxp3 intracellular staining
kit. For tetramer analysis, cells were stained with DbSmcy
PE-conjugated tetramer as described [45]. Samples were acquired
on FACScan or FACScalibur flow cytometers (BD) using Cell Quest
software (BD) and analysed using FlowJo v7.2.5 (Tree Star). Live
lymphocytes were gated by Forward Scatter (FSC) / Side Scatter
(SSC) profiles. Data represent at least three independent experi-
ments and all FACS plots shown are representative examples.
Quantitative (q)PCR
For genotyping, genomic DNA was extracted from tail tissue
using the Qiagen DNAeasy kit (Qiagen). qPCR was carried out for
genomic Gli2 as described [16].
For gene expression analysis, RNA was extracted from cells
using the Absolutely RNA miniprep kit (Agilent), and reverse
transcribed using High Capacity cDNA reverse transcription kit
(ABI). qPCR was performed in triplicate for two independent
experiments using SYBR green (Biorad) and Quantitect primers
(Qiagen) on a Biorad iCycler. Data were normalised to the
expression of Hprt and are represented as relative mean expres-
sion7SD.
Data analysis
Statistical analyses were performed using Microsoft Excel or
Prism 4 (Graph Pad). Two-tailed unpaired Student’s t-tests were
used to assess statistical significance, which was accepted at
po0.05. For three-way comparisons, one-way ANOVA was used,
stated with a significance at po0.05. All data are represented as
mean7SEM, with the exception of qPCR data, which are
displayed as stated above. Bar charts plotting mean7SEM
display the mean average and associated standard error of all
samples/mice across all experiments performed, and the number
of mice used to calculate mean7SEM is stated in figure legends.
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